Cancer52 is working with Genetic Alliance on its patient charter, My Cancer My DNA. Genetic Alliance today (8 March) has launched its new...

Cancer52 has become a partner in Genetic Alliance's 'My Cancer, My DNA' project, together with Cancer Research UK, Bloodwise and Breast...

A new study, published today (26 February) looks at the challenges of timely diagnosis for people with rarer cancers. Authored by Silvia...

The CDF Consultation closed on 11th February 2016. Cancer52 responded to the consultation: - full response - summary response

We are delighted to share the presentations delivered at the All Members Meeting held at Skipton House on 26th January: Jonathan Pearce,...

Cancer52 has published a position paper 'Cancer 52 Position Paper on Access to Medicines and Treatments' which gives a clear view on the...

On 23rd December 2015, Cancer52 published its Briefing Paper on Access to Medicines and Treatments.

Our new patient experience report - what does the evidence from the National Cancer Patient Experience Survey show us about experience...

Available for the first time at Britain Against Cancer on 8 December are two new briefings from Cancer52: "Living with a rare or less...

A briefing on the implementation of Achieving World Class Outcomes: A Strategy for England 2015-2020.